Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX:
$AVCN.TO) (TSXV: $NDVA.V) (CSE: $THC.C) (TSXV: $TEST.V)
(CSE: $EAT.C)
(TSX: $RIV.TO)
Delta, Kelowna, BC –October 21, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/10211AVCN-NDVA-THC-TEST-EAT-RIV.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In today’s
podcast we look at a few of today’s early announcements.
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on the
development, manufacturing and commercialization of organic and sustainable
plant-derived cannabinoid-based products, announced the retail launch of its Pura Earth™
derma-cosmetics line of CBD products, which are now available at approximately
59 high-end retail locations throughout Colombia, including Blind prestige
beauty shops and Cromantic professional beauty markets.
Avicanna's
Anti-Aging Treatment, Anti-Aging Serum, Clear Skin Treatment and Intensive Skin
Conditioning Treatment, which are the first four of the nine Pura Earth product
lines, are currently available at retail. Additionally the Pura Earth line will
be offered on e-commerce platforms, including Percos, Cormantic, and Blind, as
well as Avicanna's own platform, which is currently dedicated to Pura Earth.
The
registration of the Pura Earth products as final products in Colombia will
enable Avicanna to export such products into international jurisdictions that
permit such products. Avicanna expects to launch the Pura Earth brand in
additional international jurisdictions in early-2020.
The
Pura Earth products were produced with Avicanna's proprietary formulations
using cannabidiol ("CBD")
isolate extracted by the Company's majority owned subsidiary, Santa Marta
Golden Hemp S.A.S. ("SMGH"),
from cannabis grown and cultivated by SMGH in Santa Marta, Colombia. SMGH's CBD
isolate is derived from its USDA organic certified hemp (non-psychoactive
cannabis). Additionally, the Pura Earth products will be supported by clinical
data from studies conducted by the Centro de Atención e Investigación Médica
CAIMED S.A.S. in collaboration with Avicanna.
"We
are thrilled to start offering customers the world's first premium CBD skin
care line with advanced formulations and substantiated claims through clinical
evidence. The initial launch of Pura Earth in Colombia at these prestige beauty
retailers is just the beginning of our global commercial strategy. Our vertically integrated operations have the
scalability to support manufacturing a full range of premium CBD products and
supply the global marketplace," stated Aras Azadian, Avicanna's Chief
Executive Officer.
Colombia
is one of the top four cosmetics markets in Latin America showing high growth
rate in the cosmetics industry. The Latin America cosmetics industry is
continuously expanding and has placed itself as one of the fastest growing and
most vibrant cosmetic markets across the world. As per Goldstein Research,
Latin America cosmetics market has reached a value of USD $31.98 billion in
2017 and is anticipated to grow at a CAGR of 4.49% during the forecast period
2017-2025.
Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF) announced that Health Canada has approved its
licence amendment, adding 10,000 square feet of production space, including
three new grow rooms and two additional processing rooms. This additional
square footage will, subject to applicable regulatory approvals, be used to
manufacture edibles, increase Indiva's flower production capacity, and enable
new growth in the production, manufacturing, processing and refinement arms of
the business.
"We
are excited to open up these five additional rooms. This new space
significantly increases Indiva's revenue potential by adding more capacity to
our production, processing and refinement operations," Niel Marotta,
Indiva's President and Chief Executive Officer, said. "The approval of
this licence amendment powers the next step in our journey; infusing our cannabis
into gourmet chocolate as well as other derivative products. We stand committed
to following Health Canada's regulations and are proud to receive clearance to
continue forward with our strategy to meet the expectations of our supply
agreements with provincial wholesalers. We look forward to bringing our
exceptional cannabis and cannabis-infused products to more Canadians."
Indiva
intends to begin populating its three new flower rooms immediately. The
cannabis grown in this space is expected to be turned into flower, pre-rolls,
oil and distillate. The two newly-licensed processing rooms are expected to be
dedicated to Indiva's pre-roll production and chocolate manufacturing
operation.
Indiva
also announced plans to submit its evidence package to Health Canada for the
final phase of its London, Ontario facility by the end of October. Once
licensed, this will provide an additional 10,000 square feet of processing
space.
THC BioMed Intl
Ltd. (CSE: THC) (OTC: THCBF) announced that it has purchased, through its
subsidiary THC BioMed Ltd., an additional strata lot in the industrial complex
in Kelowna it currently occupies.
THC
previously announced the purchase of additional strata units in the same
building in July, April, March and January of this year and in December,
October, and June of 2018.
THC
purchased this property as a part of its expansion plan due to high demand for
its products. The new strata lot will be used for production purposes.
The
purchase price was $391,500 plus fees and taxes, for a total of $400,148.82.
THC purchased the strata lot for cash and did not require a mortgage.
FluroTech
Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on the
analytical cannabis and hemp testing market, announced that it has been selected as one of the
top 15 up and coming startups of the year by StartUp Calgary. As a result of
its selection FluroTech will have a booth at the 10th Annual Launch
Party at The Big Four in Stampede Park in Calgary on Tuesday, November 12 from
6:00 PM to 9:00 PM. Anyone interested in learning more about FluroTech or any
of the other great Calgary startups are encouraged to join the evening’s
festivities.
“We appreciate the community nominations
and the recognition by StartUp Calgary of our efforts. Transitioning from the
research stage to sales is a major milestone for the Company this year,” stated
Danny Dalla-Longa Chief Executive Officer. “We are excited to showcase
FluroTech and the CompleTest™ amongst an amazing cohort of startups,
entrepreneurs, community leaders and investors.”
FluroTech’s proprietary spectroscopy-based
technology was originally developed by Dr. Elmar Prenner at the University of Calgary
and is now being commercialized for the cannabis and hemp industries. The
CompleTest™, an affordable and easy-to-use analytical testing device, allows
growers, brokers, and extractors of cannabis to reliably and accurately test
for potency or contaminants in a fast and affordable manner.
Nutritional High International Inc. (CSE: EAT) (OTCQB: SPLIF) announced that it has entered into a five-year
binding framework agreement with Golden
Triangle Health Company Ltd. to manufacture and distribute branded products
in North America, effective immediately. To begin, Golden Triangle clients will
import products to the US to be infused and packaged.
Golden
Triangle is a Thailand-based health and wellness company with a strong family
of brands including Smooth-E, P80 Natural Essence, Siang Pure Oil, SLC Clinic
and the Traditional Thai Herbal Association. Golden Triangle is actively soliciting
additional brands from Asia to its portfolio specifically with the purpose of
manufacturing and distributing CBD and Cannabis infused products in North
America and once permitted, in Asia and Europe. Nutritional High will be
responsible for providing North American market assessments for the Clients’
products, and for those products selected will be responsible for infusion,
packaging, marketing, distribution and sales of those products in jurisdictions
where they are legal.
Products
targeted for import already have a strong following in Asia and will initially
include: P80 Natural Essence, an all-natural Longan juice clinically proven to
improve sleep and made using an exclusive manufacturing process; Siang Pure Oil
Red, a topical oil derived from 100% natural herbal ingredients and designed to
relieve various bodily discomforts such as aches and insect bites; and Smooth-E
Facial Cream, recommended by dermatologists and pharmacists to diminish scars,
heal chapped skin and smooth away wrinkles. Nutritional High will also work
closely with SLC Clinic and the Traditional Thai Herbal Association to bring
additional brands and product lines to North America. SLC Clinic is the leading
provider of skin care solutions in Thailand and the Traditional Thai Herbal
Association has proprietary formulations for an array of organic herbal
products including food, drinks, bath and body, cosmetics, and skin care.
As per
the Agreement, the Company will receive a sales fee totaling 35% of gross
sales, as well as a fee for each initial product assessment plus applicable
expenses. The Company will receive 75% of the sales fee and Golden Triangle
will receive 25%. As consideration for entering into the Agreement, Nutritional
High has issued 1,050,000 common shares of the Company to Golden Triangle.
“We are
proud to have attracted Golden Triangle as a key strategic partner to allow us
to be a first mover in Asian focused products, and eventually in Asia,”
commented Nutritional High CEO, Adam Szweras. “Golden Triangle is licensing
successful products throughout Asia and this partnership allows us to leverage
our extensive distribution network and robust manufacturing footprint for a
brand-new emerging category with limited risk.”
The
partnership between Golden Triangle and Nutritional High is a result of the
collaborative efforts between the Company and Tom Kruesopon. Based in Thailand,
Mr. Kruesopon is a political operator and businessman who played a major role
in advocating for cannabis legalization in his home country. Cannabis was
legalized for medical use in Thailand in December 2018.
“The
cannabis industry in Thailand is still in its infancy but there are a plethora
of opportunities in North America,” added Mr. Kruesopon. “Nutritional High is
building a strong brand offering and combined with their existing
infrastructure, is the perfect partner for Golden Triangle’s foray into North
America. The reverse is true as well. As we see the cannabis industry mature in
Thailand and the rest of Asia, Nutritional High will have a dedicated partner
on the other side of the Pacific ready to expand into Asian markets as
regulations permit.”
Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in
cannabis, will report its second quarter fiscal
year 2020 financial results
before market’s open on Thursday, November 14, 2019.
The
Company's unaudited condensed interim consolidated financial statements and
management's discussion and analysis of financial results for the six months
ended September 30, 2019 will be available on the Company's profile on the
System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/investors/financials-and-public-filings.
Certain
preliminary financial information pertaining to the Company may also be found
in the financial results released by Canopy
Growth Corporation (TSX: WEED) (NYSE: CGC), which are currently scheduled to be
released on November 14, 2019. All financial information with respect to the
quarter pertaining to the Company in the financial results of Canopy Growth
Corporation are preliminary and are unaudited and subject to change and
adjustment as the Company prepares its consolidated financial statements for
the six months ended September 30, 2019. Accordingly, investors are cautioned
not to place undue reliance on the preliminary financial information. The
preliminary financial results constitute "forward-looking
information" within the meaning of applicable Canadian securities laws and
are subject to a number of risks and uncertainties. Actual results may differ
materially. See "Forward-looking Statements".
Following
the release of its second quarter fiscal year 2020 financial results, Canopy
Rivers will host a conference call and audio webcast with Narbe Alexandrian,
President and CEO and Eddie Lucarelli, CFO at 10:00 AM Eastern Time on November
14, 2019.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas Investorideas.com is a recognized news source
publishing third party news, research and original financial content. Learn
about investing in stocks and sector trends with our news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column, Cleantech and
Climate Change , Exploring Mining
the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment